OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
SGLT2 Inhibitors Through the Windows of EMPA-REG and CANVAS Trials: A Review
Ashu Rastogi, Anil Bhansali
Diabetes Therapy (2017) Vol. 8, Iss. 6, pp. 1245-1251
Open Access | Times Cited: 50
Ashu Rastogi, Anil Bhansali
Diabetes Therapy (2017) Vol. 8, Iss. 6, pp. 1245-1251
Open Access | Times Cited: 50
Showing 26-50 of 50 citing articles:
Adjunct Antihyperglycemic Agents in Overweight and Obese Adults With Type 1 Diabetes
Diana Isaacs, Stephanie Yager, Marcie Parker, et al.
Annals of Pharmacotherapy (2018) Vol. 53, Iss. 4, pp. 371-384
Closed Access | Times Cited: 10
Diana Isaacs, Stephanie Yager, Marcie Parker, et al.
Annals of Pharmacotherapy (2018) Vol. 53, Iss. 4, pp. 371-384
Closed Access | Times Cited: 10
Diastolic Heart Failure
Don Goldstein, William H. Frishman
Cardiology in Review (2020) Vol. 29, Iss. 2, pp. 82-88
Closed Access | Times Cited: 10
Don Goldstein, William H. Frishman
Cardiology in Review (2020) Vol. 29, Iss. 2, pp. 82-88
Closed Access | Times Cited: 10
Cardiometabolic risk factor control in black and white people in the United States initiating sodium‐glucose co‐transporter‐2 inhibitors: A real‐world study
Olga Montvida, Subodh Verma, Jonathan E. Shaw, et al.
Diabetes Obesity and Metabolism (2020) Vol. 22, Iss. 12, pp. 2384-2397
Open Access | Times Cited: 10
Olga Montvida, Subodh Verma, Jonathan E. Shaw, et al.
Diabetes Obesity and Metabolism (2020) Vol. 22, Iss. 12, pp. 2384-2397
Open Access | Times Cited: 10
Diuretics and risk of lower extremity amputation amongst patients with insulin-treated type 2 diabetes – exploring the mechanism of possible sodium glucose co-transporter 2 inhibitor induced risk of lower extremity amputations
Afnan Alshnbari, Mohammed Alkharaiji, Uchenna Anyanwagu, et al.
Current Medical Research and Opinion (2020) Vol. 36, Iss. 12, pp. 1985-1989
Closed Access | Times Cited: 9
Afnan Alshnbari, Mohammed Alkharaiji, Uchenna Anyanwagu, et al.
Current Medical Research and Opinion (2020) Vol. 36, Iss. 12, pp. 1985-1989
Closed Access | Times Cited: 9
Management of type 2 diabetes for prevention of cardiovascular disease. An expert opinion of the Italian Diabetes Society
Raffaele Napoli, Gloria Formoso, Salvatore Piro, et al.
Nutrition Metabolism and Cardiovascular Diseases (2020) Vol. 30, Iss. 11, pp. 1926-1936
Closed Access | Times Cited: 8
Raffaele Napoli, Gloria Formoso, Salvatore Piro, et al.
Nutrition Metabolism and Cardiovascular Diseases (2020) Vol. 30, Iss. 11, pp. 1926-1936
Closed Access | Times Cited: 8
Cardiovascular profile of pharmacological agents used for the management of polycystic ovary syndrome
Huda Alalami, Thozhukat Sathyapalan, Stephen L. Atkin
Therapeutic Advances in Endocrinology and Metabolism (2018) Vol. 10
Open Access | Times Cited: 7
Huda Alalami, Thozhukat Sathyapalan, Stephen L. Atkin
Therapeutic Advances in Endocrinology and Metabolism (2018) Vol. 10
Open Access | Times Cited: 7
Nano Architect-Based Targeted Delivery Systems for Diabetic Nephropathy: A Review
Aruna Rawat, Vikas Jhawat, Rohit Dutt
Current Drug Targets (2023) Vol. 24, Iss. 8, pp. 662-672
Closed Access | Times Cited: 2
Aruna Rawat, Vikas Jhawat, Rohit Dutt
Current Drug Targets (2023) Vol. 24, Iss. 8, pp. 662-672
Closed Access | Times Cited: 2
Qufeng tongluo decoction decreased proteinuria in diabetic mice by protecting podocytes via promoting autophagy
Boran Ni, Yao Xiao, Ruojun Wei, et al.
Journal of Traditional and Complementary Medicine (2023) Vol. 14, Iss. 3, pp. 312-320
Open Access | Times Cited: 2
Boran Ni, Yao Xiao, Ruojun Wei, et al.
Journal of Traditional and Complementary Medicine (2023) Vol. 14, Iss. 3, pp. 312-320
Open Access | Times Cited: 2
Safety and Efficacy of Gliflozin Group Among Patients with Type 2 Diabetes Including Patient’s Satisfaction in Saudi Arabia
Al Hejji R
Biomedical Journal of Scientific & Technical Research (2019) Vol. 18, Iss. 4
Open Access | Times Cited: 3
Al Hejji R
Biomedical Journal of Scientific & Technical Research (2019) Vol. 18, Iss. 4
Open Access | Times Cited: 3
Sodium–Glucose Cotransporter-2 Inhibitors and the Risk of Amputation: What Is Currently Known?
Anne Misher, Andrea Ampuero, Rebecca Phan, et al.
American Journal of Therapeutics (2020) Vol. 28, Iss. 1, pp. e96-e110
Closed Access | Times Cited: 3
Anne Misher, Andrea Ampuero, Rebecca Phan, et al.
American Journal of Therapeutics (2020) Vol. 28, Iss. 1, pp. e96-e110
Closed Access | Times Cited: 3
Glucodynamics and glucocracy in type 2 diabetes mellitus: clinical evidence and practice-based opinion on modern sulfonylurea use, from an International Expert Group (South Asia, Middle East & Africa) via modified Delphi method
Sanjay Kalra, Das A. K., Fariduddin Md, et al.
Current Medical Research and Opinion (2020) Vol. 37, Iss. 3, pp. 403-409
Open Access | Times Cited: 3
Sanjay Kalra, Das A. K., Fariduddin Md, et al.
Current Medical Research and Opinion (2020) Vol. 37, Iss. 3, pp. 403-409
Open Access | Times Cited: 3
Non-pharmacological interventions to improve cardiovascular risk factors in people with diabetic foot disease: A systematic review and meta-analysis
Patrick Highton, Abdullah Almaqhawi, Maroria Oroko, et al.
Diabetes Research and Clinical Practice (2024) Vol. 209, pp. 111590-111590
Open Access
Patrick Highton, Abdullah Almaqhawi, Maroria Oroko, et al.
Diabetes Research and Clinical Practice (2024) Vol. 209, pp. 111590-111590
Open Access
Development and Validation of USM-Insulin Adherence Module for Patients with Type 2 Diabetes Mellitus
Aida Maziha Zainudin, Aida Hanum Ghulam Rasool, Mohd Zarawi Mat Nor, et al.
Malaysian Journal of Medical Sciences (2024) Vol. 31, Iss. 2, pp. 98-112
Open Access
Aida Maziha Zainudin, Aida Hanum Ghulam Rasool, Mohd Zarawi Mat Nor, et al.
Malaysian Journal of Medical Sciences (2024) Vol. 31, Iss. 2, pp. 98-112
Open Access
Diabetic Nephropathy (Nursing)
Ron T. Varghese, Ishwarlal Jialal, Chaddie Doerr
(2021)
Closed Access | Times Cited: 3
Ron T. Varghese, Ishwarlal Jialal, Chaddie Doerr
(2021)
Closed Access | Times Cited: 3
Is there a paradigm shift in preventing diabetic heart failure? A review of SGLT2 inhibitors
Sumanth KHAKDE, Hafsa Jawaid, Farah Yasmin, et al.
Minerva Endocrinology (2022) Vol. 47, Iss. 3
Closed Access | Times Cited: 2
Sumanth KHAKDE, Hafsa Jawaid, Farah Yasmin, et al.
Minerva Endocrinology (2022) Vol. 47, Iss. 3
Closed Access | Times Cited: 2
Zaviralci SGLT-2
Mojca Lunder, Miodrag Janić, Mišo Šabovič, et al.
Slovenian Medical Journal (2018) Vol. 87, Iss. 9-10, pp. 493-506
Open Access | Times Cited: 2
Mojca Lunder, Miodrag Janić, Mišo Šabovič, et al.
Slovenian Medical Journal (2018) Vol. 87, Iss. 9-10, pp. 493-506
Open Access | Times Cited: 2
Collecting duct PGE2 responses reduce water loss with empagliflozin in mice with type 2 diabetes mellitus
R Nasrallah, Joseph Zimpelmann, Véronique Cheff, et al.
Journal of Clinical Nephrology (2021) Vol. 5, Iss. 1, pp. 023-030
Open Access | Times Cited: 2
R Nasrallah, Joseph Zimpelmann, Véronique Cheff, et al.
Journal of Clinical Nephrology (2021) Vol. 5, Iss. 1, pp. 023-030
Open Access | Times Cited: 2
Sodium-glucose co-transporter-2 inhibitors in patients with type 2 diabetes mellitus without established cardiovascular disease: Do they have a role in primary prevention?
Shailaja Kale, Abd A. Tahrani
Metabolism Open (2021) Vol. 10, pp. 100082-100082
Open Access | Times Cited: 1
Shailaja Kale, Abd A. Tahrani
Metabolism Open (2021) Vol. 10, pp. 100082-100082
Open Access | Times Cited: 1
The Extent of Use of SGLT2 Inhibitors in Patients with Type 2 Diabetes in Clinical Practice
Rutul Gokalani, Dharmendra Panchal, Banshi Saboo, et al.
Journal of Diabetology (2021) Vol. 12, Iss. 3, pp. 305-309
Open Access | Times Cited: 1
Rutul Gokalani, Dharmendra Panchal, Banshi Saboo, et al.
Journal of Diabetology (2021) Vol. 12, Iss. 3, pp. 305-309
Open Access | Times Cited: 1
Changing the Concept: From the Traditional Glucose-centric to the New Cardiorenal-metabolic Approach for the Treatment of Type 2 Diabetes
Dimitrios Chatzis, Konstantinos Kolokathis, Kalliopi Magounaki, et al.
touchREVIEWS in Endocrinology (2021) Vol. 17, Iss. 2, pp. 92-92
Open Access | Times Cited: 1
Dimitrios Chatzis, Konstantinos Kolokathis, Kalliopi Magounaki, et al.
touchREVIEWS in Endocrinology (2021) Vol. 17, Iss. 2, pp. 92-92
Open Access | Times Cited: 1
Gliflozins and their beneficial hypoglycaemic effect profile and prevention of cardiovascular complications in patients treated for type II diabetes mellitus
Natalia Sobańska, Rafał Teichman, Aleksandra Paulina Banasiak, et al.
Quality in Sport (2023) Vol. 9, Iss. 2, pp. 11-17
Open Access
Natalia Sobańska, Rafał Teichman, Aleksandra Paulina Banasiak, et al.
Quality in Sport (2023) Vol. 9, Iss. 2, pp. 11-17
Open Access
Consejos prácticos de rehabilitación cardiaca para los pacientes con cardiopatía isquémica
Sonia Ruiz, Consol Ivern Díaz, Neus Badosa, et al.
FMC - Formación Médica Continuada en Atención Primaria (2018) Vol. 25, Iss. 9, pp. 539-546
Closed Access
Sonia Ruiz, Consol Ivern Díaz, Neus Badosa, et al.
FMC - Formación Médica Continuada en Atención Primaria (2018) Vol. 25, Iss. 9, pp. 539-546
Closed Access
Association of serum osteocalcin with beta cell function, insulin resistance, and glycemic parameters in south Indian type 2 diabetic subjects
Vinay Kumar, Nandakrishna Bolanthakodi, Sudha Vidyasagar, et al.
International Journal of Diabetes in Developing Countries (2022) Vol. 43, Iss. 3, pp. 469-475
Closed Access
Vinay Kumar, Nandakrishna Bolanthakodi, Sudha Vidyasagar, et al.
International Journal of Diabetes in Developing Countries (2022) Vol. 43, Iss. 3, pp. 469-475
Closed Access
